| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 85.6K | $1.03M | - | |
| VP | 42.7K | $514.3K | - | |
| COO | 13.5K | $162.3K | - | |
| CFO | 7.6K | $91.8K | - | |
| VP | 4.6K | $55.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2018 | Steven B Ketchum | Chief Scientific Officer | Sale+OE | 17,042 | $20.74 | $353,453.86 | -4.8% | |
| Oct 31, 2018 | Joseph T Kennedy | General Counsel | Sale+OE | 23,307 | $20.74 | $483,362.25 | -9.7% | |
| Oct 1, 2018 | Joseph T Kennedy | General Counsel | Sale+OE | 50,249 | $16.81 | $844,528.35 | -18.7% | |
| Oct 1, 2018 | Steven B Ketchum | Chief Scientific Officer | Sale+OE | 316,604 | $16.13 | $5,105,588.80 | -48.1% | |
| Sep 25, 2018 | Steven B Ketchum | Chief Scientific Officer | Sale+OE | 879,241 | $11.10 | $9,760,023.88 | -72.0% | |
| Sep 24, 2018 | Joseph T Kennedy | General Counsel | Sale+OE | 1,079,706 | $10.56 | $11,400,975.47 | -83.2% | |
| Sep 24, 2018 | Joseph S Zakrzewski55 | Director | Sale+OE | 500,000 | $10.60 | $5,299,333.58 | -68.9% | |
| Sep 24, 2018 | Michael Wayne Kalb | SVP and CFO | Sale+OE | 150,000 | $10.42 | $1,562,750.82 | -90.9% | |
| Jul 2, 2018 | Joseph T Kennedy | General Counsel | Sale+OE | 26,942 | $3.00 | $80,955.32 | -59.4% | |
| Apr 3, 2018 | Joseph T Kennedy | General Counsel | Sale+OE | 26,942 | $2.90 | $78,072.14 | -59.4% |